Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Neoplasms, Germ Cell and Embryonal × Sorafenib × 1 year × Clear all

Sponsor

Conditions

Carcinoma, Hepatocellular 16 Leukemia, Myeloid, Acute 7 Neoplasms 4 Liver Neoplasms 4 Thyroid Neoplasms 2 Squamous Cell Carcinoma of Head and Neck 2 Neoplasm Metastasis 2 Fibrolamellar hepatocellular carcinoma 2 Tongue Neoplasms 1 Thyroid cancer, Hurthle cell 1 Thyroid Diseases 1 Sarcoma, Myeloid 1 Salivary Gland Neoplasms 1 Rhabdomyosarcoma 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Neuroectodermal Tumors, Primitive, Peripheral 1 Neuroblastoma 1 Neoplasm, Residual 1 Myelodysplastic Syndromes 1 Metastatic Colorectal Cancer Patients With KRAS Mutated Tumors 1 Melanoma 1 Hepatoblastoma 1 Gastrointestinal Stromal Tumors 1 Desmoplastic Small Round Cell Tumor 1 Colorectal Neoplasms 1 Carcinoma, Renal Cell 1 Carcinoma 1 Brain Neoplasms 1

Interventions

Cisplatin 7 Etoposide 6 fludarabine 4 Cyclophosphamide 4 fludarabine phosphate 3 Bleomycin 3 Automobiles 3 pralsetinib 2 pembrolizumab 2 etoposide phosphate 2 Sirolimus 2 Paclitaxel 2 Mesna 2 Drug Therapy 2 Carboplatin 2 130-nm albumin-bound paclitaxel 2 tremelimumab 1 tozuleristide 1 sodium thiosulfate 1 repotrectinib 1 pegfilgrastim 1 lutetium Lu 177 dotatate 1 durvalumab 1 cabozantinib 1 Vorinostat 1 Teniposide 1 Surveys and Questionnaires 1 Stem Cell Transplantation 1 Standard of Care 1 Specimen Handling 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡